ANTHEM BIOSCIENCES LIMITED
Ownership & governance
Executives 5Directors 8Avg age 62Avg tenure 10.2y
AB
Ajay Bharadwaj
Chief Executive Officer
Age 66Since 2006-06-12Profile →
+12
Executives5
KC
K Ravindra Chandrappa→
Chief Operating Officer
Age 59Since 2006-09-26
GS
Ganesh Sambasivam→
Chief Tech/Sci/R&D Officer
Age 60Since 2006-08-03
AB
Ajay Bharadwaj→
Chief Executive Officer
Age 66Since 2006-06-12
MB
Mohammed Gawir Baig→
Director of Finance/CFO
—Since 2021-11-21
DP
Divya Prasad→
Compliance Officer
—Since 2018-01-31
Board of directors8
AB
Ajay Bharadwaj→
Chairman
Age 66Since 2020-12-31
GS
Ganesh Sambasivam→
Director/Board Member
Age 60Since 2006-08-03
KC
K Ravindra Chandrappa→
Director/Board Member
Age 59Since 2006-09-26
SS
Satish Chander Subbanna→
Director/Board Member
Age 51Since 2021-04-08
RR
Ramesh Ramadurai→
Director/Board Member
Age 64Since 2024-09-26
RU
Ravi Kant Uppal→
Director/Board Member
Age 74Since 2024-09-26
SM
Subramanian Madhavan→
Director/Board Member
Age 69Since 2024-09-26
SK
Shubha Kulkarni→
Director/Board Member
Age 59Since 2024-09-26
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Ajay Bharadwaj | 42.41 % | 238,869,615 |
| Ishaan Bhardwaj | 10.13 % | 57,048,680 |
| Ganesh Sambasivam | 8.109 % | 45,670,027 |
| K Ravindra Chandrappa | 7.75 % | 43,646,849 |
| Portsmouth Technologies LLC | 2.734 % | 15,396,327 |
Catalog · 2026-07-09
Registry officers13
| Name | Role | Since | Shares |
|---|---|---|---|
| Ajay Bharadwaj | Chairman | 2020-12-31 | - |
| Ajay Bharadwaj | Chief Executive Officer | 2006-06-12 | - |
| Ganesh Sambasivam | Chief Tech/Sci/R&D Officer | 2006-08-03 | - |
| K Ravindra Chandrappa | Chief Operating Officer | 2006-09-26 | - |
| Mohammed Gawir Baig | Director of Finance/CFO | 2021-11-21 | - |
| Ganesh Sambasivam | Director/Board Member | 2006-08-03 | - |
| K Ravindra Chandrappa | Director/Board Member | 2006-09-26 | - |
| Ramesh Ramadurai | Director/Board Member | 2024-09-26 | - |
Registry · as of 2026-07-09
Group companies
| Name | Category |
|---|---|
| Neoanthem Lifesciences Pvt Ltd. | — |
| Neoanthem Lifesciences Pvt Ltd. | — |
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 905.13Range 830–1,050Analysts 8
830Mean 905.131,050
- Strong buy 3
- Buy 5
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.